|
|
|
|
Department of Pharmacology, University of Cambridge, Cambridge, United Kingdom
Received May 11, 2004; accepted May 13, 2004
| Abstract |
|---|
|
|
|---|
|
The N- and C-terminal lobes of CaM are similar but not identical. In the absence of Ca2+, the C-terminal sites are more open than those in the N-lobe, they have
10-fold greater affinity for Ca2+, and Mg2+ dissociates more rapidly from them. The latter is important because at resting cytosolic [Ca2+], most of the Ca2+-binding sites of CaM are probably occupied by Mg2+, which must dissociate before Ca2+ can bind. The C-lobe is therefore best equipped to respond rapidly to increases in cytosolic [Ca2+]. Ca2+ binding causes twisting of the helices within the EF hand (they become almost perpendicular to each other) and, because helices from each EF hand move in concert, binding of Ca2+ to one EF hand promotes Ca2+ binding to its partner. There are also interactions between lobes and a further increase in Ca2+ affinity when the target protein binds; Ca2+ binding is thus positively cooperative (Ikura, 1996
) and the affinity of CaM for Ca2+ is tuned by its association with target proteins (Jurado et al., 1999
). These Ca2+-evoked conformational changes (Fig. 1C) cause CaM to expose a concave hydrophobic surface (Vetter and Leclerc, 2003
) to which target proteins can bind via positively charged amphiphilic
-helices (Rhoads and Friedberg, 1997
).
Not all interactions with CaM require Ca2+ (Jurado et al., 1999
). CaM is permanently associated with some proteins, some reversibly associate only with apoCaM, and others bind CaM whether or not it has Ca2+ bound. Accumulating evidence suggests that Ca2+-independent anchoring of CaM to Ca2+-regulated channels may be an important means of ensuring that the Ca2+ sensor is placed to allow rapid responses to changes in [Ca2+] (Xia et al., 1998
; Liang et al., 2003
; Zamponi, 2003
). IQ motifs (IQxxxRGxxxR) commonly mediate Ca2+-independent binding to CaM (Rhoads and Friedberg, 1997
), but they are not the only sequences to mediate such interactions, nor is binding of CaM to all IQ motifs Ca2+-independent (Jurado et al., 1999
). An important point is exemplified by glycogen phosphorylase b kinase with which CaM is permanently associated: the interaction is mediated by two distinct sites in the
subunit, neither of which binds CaM in the absence of Ca2+, yet together they are sufficient to mediate a stable interaction even in the absence of Ca2+ (Dasgupta et al., 1989
). Such synergistic binding highlights the difficulty of trying to identify physiologically important CaM-binding sites using peptide fragments of target proteins. Intimate associations between CaM and its targets tend also to be resistant to disruption by conventional or peptide antagonists (Xia et al., 1998
; Krupp et al., 1999
; Peterson et al., 1999
). Furthermore, peptides derived from sites known to bind apoCaM in the native protein often bind preferentially to Ca2+-CaM in isolation (Jurado et al., 1999
). Each of these features contributes to the considerable difficulties associated with defining the roles of CaM in mediating Ca2+ regulation of channels.
| Tethered CaM: Poised to Regulate Voltage-Gated Ca2+ Channels |
|---|
|
|
|---|
1C) subunit of the L-type Ca2+ channel, three sequences, including an IQ motif, are capable of binding CaM (Tang et al., 2003
A similar mechanism underlies CDI of other voltage-gated Ca2+ channels but with an intriguing difference: whereas Ca2+ must bind to the C-lobe of CaM for inactivation of L-type channels, it binds to the N-lobe to inactivate P/Q, R, and N-type channels (Liang et al., 2003
). The difference allows CDI of L-type channels to be driven by local Ca2+ signals (detected by the C-lobe with its ability to bind Ca2+ quickly; see above), whereas slower binding to the low-affinity N-lobe tailors CDI of the other Ca2+ channels to global Ca2+ signals (Fig. 1E).
For P/Q-type channels, there is an additional wrinkle. Global Ca2+ signals detected by the N-lobe of tethered CaM mediate CDI, whereas local Ca2+ signals detected by the C-lobe cause rapid Ca2+-dependent facilitation (DeMaria et al., 2001
). Such versatility is possible only because the two lobes of CaM respond differently to rapid increases in [Ca2+] and because CaM can be tethered near the mouth of the channel, where it is optimally poised both to detect and regulate channel activity. Voltage-gated Ca2+ channels thus provide exquisite examples of how spatial organization and the kinetics of Ca2+ sensors can be tailored to allow selective decoding of Ca2+ signals.
Tethered CaM also mediates Ca2+ regulation of K+ channels (Xia et al., 1998
). For other channels too, including TRP proteins, cyclic nucleotide-gated channels, and N-methyl-D-aspartate receptors, CaM is involved in Ca2+ regulation, and although the mechanisms may differ, a common theme is disruption of protein-protein interactions by Ca2+-CaM.
| Ca2+ Regulation of Intracellular Ca2+ Channels |
|---|
|
|
|---|
After years during which many different CaM-binding sites were proposed to exist on RyR1, the consensus now is that each subunit binds both apoCaM and Ca2+-CaM, but the sites overlap such that apoCaM is tethered by its C-lobe and then shifts within the overlapping sites when it binds Ca2+ (Rodney et al., 2001b
; Zhang et al., 2003
). The shift allows it to inhibit the channel, and CaM12 is as effective as wild-type CaM in mediating the inhibition (Rodney et al., 2001a
). The N-lobe of CaM, which is required for inhibition even though it need not bind Ca2+, seems to interact with a different site on a neighboring subunit: CaM may thereby tie one RyR1 subunit to another (Zhang et al., 2003
). This is interesting because Cys residues near these CaM-binding sites also cross-link RyR1 subunits and mediate effects of oxidation on channel opening. One appealing suggestion (Xiong et al., 2002
) is that CaM is tethered by both lobes and edges along its binding site when its C-lobe binds Ca2+, the movement then causing rearrangement of the interaction between subunits, leading ultimately to channel inhibition (Fig. 1F).
For IP3R, the situation is more confusing. Ca2+ inhibits all IP3Rs. There is evidence that such inhibition may result from Ca2+ binding directly to the receptor, but competing evidence (reviewed in Taylor and Laude, 2002
) implicates additional Ca2+-binding proteins, and CaM is the most likely candidate (Adkins et al., 2000
), not least because it has been reported to restore Ca2+-inhibition to purified IP3R (Michikawa et al., 1999
). Because IP3R1 has received most attention, we consider only this subtype. A split site near the N terminus binds both apoCaM and Ca2+-CaM and seems to mediate Ca2+-independent inhibition of IP3 binding (Patel et al., 1997
). It is curious, however, that CaM has never been shown to inhibit IP3R function in the absence of Ca2+. A more central site forms a typical Ca2+-CaM binding site and mutation of its central Trp residue reduces its ability to bind CaM (Yamada et al., 1995
). In functional assays, this mutation has consistently failed to affect inhibition of IP3R by Ca2+ or CaM (Zhang and Joseph, 2001
; Nosyreva et al., 2002
). We have suggested that this region also binds apoCaM and that the point mutation fails to completely abolish CaM binding (Adkins et al., 2000
). An article in this issue of Molecular Pharmacology (Nadif Kasri et al., 2004
) explores this further and shows (rather like results from RyR1) that overlapping sites within this area bind both apoCaM and Ca2+-CaM, such that Ca2+ binding might cause CaM to move toward the C-terminal of the site. The newly revealed complexity of this site re-ignites the possibility that it may contribute to CaM-regulation of IP3R, although its absence from IP3R3, which is also inhibited by CaM, would then be difficult to explain. A third site, which also binds only Ca2+-CaM, is created only after removal of the S2 splice site of IP3R1 (Lin et al., 2000
); its role is unknown. Clearly, Ca2+-CaM inhibits IP3Rs, but the sites through which it exerts that inhibition are unresolved, and is it unclear whether CaM is exclusively responsible for Ca2+ inhibition. We have suggested (Taylor and Laude, 2002
; Taylor et al., 2004
), in analogy with L-type Ca2+ channels and RyRs, that CaM may be constitutively tethered by one lobe to IP3R1 (possibly via the N-terminal Ca2+-independent CaM-binding site); then, when the second lobe binds Ca2+, it binds to another site on a different subunit to inhibit channel opening. However, we need better tools to test such speculations.
At first sight, suramin, which displaces both Ca2+-CaM and apoCaM from RyR1 (Papineni et al., 2002
) looks like a promising means of disentangling the complex effects of CaM on IP3R. In this issue of Molecular Pharmacology, Nadif Kasri et al. (2004
) show that suramin does indeed block all CaM binding to IP3R irrespective of the free [Ca2+]. However, suramin is rather like heparin in that it behaves as a competitive antagonist of IP3; it reduces the sensitivity of Ca2+ release to IP3 and it displaces IP3 from its binding site. The authors considered this possibility, of course, and claimed to eliminate it by demonstrating that suramin effectively reduces [3H]IP3 binding to the N-terminal fragment (residues 1581) that includes a CaM-binding site, but not to a shorter fragment (226581). The observation is correct, but the conclusion is not. Because the shorter fragment binds IP3 with much greater affinity (Uchiyama et al., 2002
), higher concentrations of antagonist are required to displace [3H]IP3 from it. In our hands, similar fragments of IP3R1 (1604 and 224604) differ by about 40-fold in their affinities for IP3 (KD = 5.98 ± 1.13 and 0.14 ± 0.08 nM, respectively). Suramin displaces [3H]IP3 from both, although higher concentrations are required to displace it from the smaller fragment (IC50 = 10.3 ± 0.6 and 129 ± 12 µM, for the long and short fragments, respectively; Fig. 2). After correcting for the different affinities for IP3, it is clear that both fragments one with and one without the CaM-binding site bind suramin with similar affinity (KD = 9.24 ± 0.6 and 20.7 ± 2.0 µM, for the long and short fragments, respectively). Plainly suramin is yet another of the low-affinity, polysulfated competitive antagonists of the IP3R.
|
Despite its limitations, what can suramin tell us about the effects of CaM on IP3R? At concentrations that prevent IP3Rs from binding to CaM-Sepharose, suramin does not affect biphasic regulation of IP3R by cytosolic Ca2+, although the extent of the inhibition was surprisingly small. This might suggest that CaM cannot provide the Ca2+ sensor that mediates Ca2+ inhibition, but it is notoriously difficult (see above) to pharmacologically disrupt the association of endogenous CaM with its targets. In none of these experiments was suramin shown to dissociate endogenous CaM from full-length IP3Rs. More interesting is the observation that CaM1234 effectively mimics the effects of CaM: both potentiate Ca2+ inhibition (Nadif Kasri et al., 2004
). This surprising result is very different from the effect of CaM1234 on other Ca2+-regulated channels, where it behaves as an antagonist by displacing endogenous Ca2+-responsive CaM. For IP3R1, then, the effects of CaM are wholly independent of its ability to bind Ca2+, but the CaM can inhibit only when the IP3R has bound Ca2+. Many sites to which Ca2+ binds on IP3R1 (Sienaert et al., 1997
) could mediate the effect of Ca2+, but where does the CaM bind? The N-terminal CaM-binding site deserves consideration, but in the intact IP3R, both CaM binding to it (unlike the "apoCaM"-binding site of L-type channels) and the effect of CaM on IP3 binding are entirely unaffected by Ca2+ (Patel et al., 1997
). This site might therefore be responsible for CaM tethering, but it seems unlikely to mediate a response to Ca2+. Perhaps, in analogy with the behavior of CaM at other Ca2+-regulated channels, the work from Nadif Kasri et al. should prompt us into looking for another apoCaM-binding site, access to which is regulated by Ca2+ binding to the IP3R.
| Footnotes |
|---|
Article, publication date, and citation information can be found at http://molpharm.aspetjournals.org.
ABBREVIATIONS: CaM, calmodulin; CDF, Ca2+-dependent facilitation; CDI, Ca2+-dependent inactivation; IP3R, inositol 1,4,5-trisphosphate receptor; RyR, ryanodine receptor.
Address correspondence to: Colin W. Taylor, Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1PD, UK. E-mail: cwt1000{at}cam.ac.uk
| References |
|---|
|
|
|---|
Adkins CE and Taylor CW (1999) Lateral inhibition of inositol 1,4,5-trisphosphate receptors by cytosolic Ca2+. Curr Biol 9: 11151118.[CrossRef][Medline]
Celio MR, Pauls TL and Schwaller B (1996) Guidebook to the Calcium-Binding Proteins. Oxford University Press, Oxford, UK.
Chin D and Means AR (2000) Calmodulin: a prototypical calcium sensor. Trends Cell Biol 10: 322328.[CrossRef][Medline]
Dasgupta M, Honeycutt T, and Blumenthal DK (1989) The
-subunit of skeletal muscle phosphorylase kinase contains two noncontiguous domains that act in concert to bind calmodulin. J Biol Chem 264: 1715617163.
DeMaria CD, Soong TW, Alseikhan BA, Alvania RS, and Yue DT (2001) Calmodulin bufurcates the local Ca2+ signal that modulates P/Q-type Ca2+ channels. Nature (Lond) 411: 484489.[CrossRef][Medline]
Erickson MG, Alseikhan BA, Peterson BZ, and Yue DT (2001) Preassociation of calmodulin with voltage-gated Ca2+ channels revealed by FRET in single living cells. Neuron 31: 973985.[CrossRef][Medline]
Geiser JR, van Tuinen D, Brockerhoff SE, Neff MM, and Davis TN (1991) Can calmodulin function without binding calcium. Cell 65: 949959.[CrossRef][Medline]
Ikura M (1996) Calcium binding and conformational response in EF-hand proteins. Trends Biochem Sci 21: 1417.[CrossRef][Medline]
Jurado LA, Chockalingam PS, and Jarrett HW (1999) Apocalmodulin. Physiol Rev 79: 661682.
Krupp JJ, Vissel B, Thomas CG, Heinemann SF, and Westbrook GL (1999) Interactions of calmodulion and
-actinin with the NR1 subunit modulate Ca2+-dependent inactivation of NMDA receptors. J Neurosci 19: 11651176.
Liang H, DeMaria CD, Erickson MG, Mori MX, Alseikhan BA, and Yue DT (2003) Unified mechanisms of Ca2+ regulation across the Ca2+ channel family. Neuron 39: 951960.[CrossRef][Medline]
Lin C, Widjaja J, and Joseph SK (2000) The interaction of calmodulin with alternatively spliced isoforms of the type-I inositol trisphosphate receptor. J Biol Chem 275: 23052311.
Michikawa T, Hirota J, Kawano S, Hiraoka M, Yamada M, Furuichi T, and Mikoshiba K (1999) Calmodulin mediates calcium-dependent inactivation of the cerebellar type 1 inositol 1,4,5-trisphosphate receptor. Neuron 23: 799808.[CrossRef][Medline]
Nadif Kasri N, Bultynck G, Sienaert I, Callewaert G, Erneux C, Missiaen L, Parys JB, and De Smedt H (2002) The role of calmodulin for inositol 1,4,5-trisphosphate receptor function. Biochim Biophys Acta 1600: 1931.[Medline]
Nadif Kasri N, Bultynck G, Smyth J, Szlufcik K, Parys J, Callewaert G, Missiaen L, Fissore RA, Mikoshiba K, and De Smedt H (2004) The N-terminal Ca2+-independent calmodulin-binding site on the inositol 1,4,5-trisphosphate receptor is responsible for calmodulin inhibition, even though this inhibition requires Ca2+. Mol Pharmacol 66: 276284.
Nosyreva E, Miyakawa T, Wang Z, Glouchankova L, Iino M and Bezprozvanny I (2002) The high-affinity calcium-calmodulin-binding site does not play a role in the modulation of type 1 inositol 1,4,5-trisphosphate receptor function by calcium and calmodulin. Biochem J 365: 659667.[Medline]
Papineni RVL, O'Connell KMSO, Zhang H, Dirksen RT, and Hamilton SL (2002) Suramin interacts with the calmodulin binding site on the ryanodine receptor, RYR1. J Biol Chem 277: 4916749174.
Patel S, Morris SA, Adkins CE, O'Beirne G, and Taylor CW (1997) Ca2+-independent inhibition of inositol trisphosphate receptors by calmodulin: redistribution of calmodulin as a possible means of regulating Ca2+ mobilization. Proc Natl Acad Sci USA 94: 1162711632.
Peterson BZ, DeMaria CD, Adelman JP, and Yue DT (1999) Calmodulin is the Ca2+ sensor for Ca2+-dependent inactivation of L-type calcium channels. Neuron 22: 549558.[CrossRef][Medline]
Pitt GS, Zühlke RD, Hudmon A, Schulman H, Reuter H, and Tsien RW (2001) Molecular basis of calmodulin tethering and Ca2+-dependent inactivation of L-type Ca2+ channels. J Biol Chem 276: 3079430802.
Rhoads AR and Friedberg F (1997) Sequence motifs for calmodulin recognition. FASEB J 11: 331340.[Abstract]
Rodney GG, Krol J, Williams B, Beckingham K, and Hamilton SL (2001a) The carboxyterminal calcium binding sites of calmodulin control calmodulin's switch from an activator to an inhibitor of RYR1. Biochemistry 40: 1243012435.[CrossRef][Medline]
Rodney GG, Moore CP, Williams BY, Zhang J-Z, Krol J, Pedersen SE, and Hamilton SL (2001b) Calcium binding to calmodulin leads to an N-terminal shift in its binding site on the ryanodine receptor. J Biol Chem 276: 20692074.
Sienaert I, Missiaen L, De Smedt H, Parys JB, Sipma H, and Casteels R (1997) Molecular and functional evidence for multiple Ca2+-binding domains on the type 1 inositol 1,4,5-trisphosphate receptor. J Biol Chem 272: 2589925906.
Tang W, Halling DB, Black DJ, Pate P, Zhang J-Z, Pedersen S, Altschuld RA, and Hamilton SL (2003) Apocalmodulin and Ca2+ calmodulin-binding sites on the Cav1.2 channel. Biophys J 85: 15381547.[Medline]
Taylor CW, da Fonseca PCA, and Morris EP (2004) IP3 receptors: the search for structure. Trends Biochem Sci 29: 210219.[CrossRef][Medline]
Taylor CW and Laude AJ (2002) IP3 receptors and their regulation by calmodulin and cytosolic Ca2+. Cell Calcium 32: 321334.[CrossRef][Medline]
Uchiyama T, Yoshikawa F, Hishida A, Furuichi T, and Mikoshiba K (2002) A novel recombinant hyper-affinity inositol 1,4,5-trisphosphate (IP3) absorbent traps IP3, resulting in specific inhibition of IP3-mediated calcium signaling. J Biol Chem 277: 81068113.
Vetter SW and Leclerc E (2003) Novel aspects of calmodulin recognition and activation. Eur J Biochem 270: 404414.[Medline]
Xia X-M, Fakler B, Rivard A, Wayman G, Johnson-Pais T, Keen JE, Ishii T, Hirschberg B, Bond CT, Lutsenko S, et al. (1998) Mechanisms of calcium gating in small-conductance calcium-activated potassium channels. Nature (Lond) 395: 503507.[CrossRef][Medline]
Xiong L-W, Newman RA, Rodney GG, Thomas O, Zhang J-Z, Persechini A, Shea MA, and Hamilton SL (2002) Lobe-dependent regulation of ryanodine receptor type 1 by calmodulin. J Biol Chem 277: 4086240870.
Yamada M, Miyawaki A, Saito K, Yamamoto-Hino M, Ryo Y, Furuichi T, and Mikoshiba K (1995) The calmodulin-binding domain in the mouse type 1 inositol 1,4,5-trisphosphate receptor. Biochem J 308: 8388.
Zamponi GW (2003) Calmodulin lobotomized: novel insights into calcium regulation of voltage-gated calcium channels. Neuron 39: 879881.[CrossRef][Medline]
Zhang H, Zhang J-Z, Danila CI, and Hamilton SL (2003) A noncontiguous, intersubunit binding site for calmodulin on the skeletal muscle Ca2+ release channel. J Biol Chem 278: 83488355.
Zhang X and Joseph SK (2001) Effect of mutation of a calmodulin-binding sites on Ca2+ regulation of inositol trisphosphate receptors. Biochem J 360: 395400.[CrossRef][Medline]
This article has been cited by other articles:
![]() |
J. K. Foskett, C. White, K.-H. Cheung, and D.-O. D. Mak Inositol Trisphosphate Receptor Ca2+ Release Channels Physiol Rev, April 1, 2007; 87(2): 593 - 658. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||